168 related articles for article (PubMed ID: 33449116)
21. Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
Nyuykonge B; Lim W; van Amelsvoort L; Bonifaz A; Fahal A; Badali H; Abastabar M; Verbon A; van de Sande W
Mycoses; 2022 Jun; 65(6):650-655. PubMed ID: 35398930
[TBL] [Abstract][Full Text] [Related]
22. Mycetoma in north-western Yemen: Clinico-epidemiological and histopathological study.
Khatri ML; Al Kubati SAS; Gaffer IA; Majeed SMA
Indian J Dermatol Venereol Leprol; 2022; 88(5):615-622. PubMed ID: 35389029
[TBL] [Abstract][Full Text] [Related]
23. New species of Madurella, causative agents of black-grain mycetoma.
de Hoog GS; van Diepeningen AD; Mahgoub el-S; van de Sande WW
J Clin Microbiol; 2012 Mar; 50(3):988-94. PubMed ID: 22205798
[TBL] [Abstract][Full Text] [Related]
24. The developed molecular biological identification tools for mycetoma causative agents: An update.
Siddig EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ
Acta Trop; 2022 Jan; 225():106205. PubMed ID: 34687643
[TBL] [Abstract][Full Text] [Related]
25. Eumycetoma due to Madurella mycetomatis acquired in Jamaica.
Fletcher CL; Moore MK; Hay RJ
Br J Dermatol; 2001 Dec; 145(6):1018-21. PubMed ID: 11899126
[TBL] [Abstract][Full Text] [Related]
26. Mycetoma caused by Microascus gracilis: a novel agent of human eumycetoma in Sudan.
Mhmoud NA; Siddig EE; Nyuykonge B; Bakhiet SM; van de Sande WWJ; Fahal AH
Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):426-430. PubMed ID: 33515449
[TBL] [Abstract][Full Text] [Related]
27. Invasive, aggressive mastoid bone eumycetoma: a treatment challenge.
Yosif AA; Bakhiet SM; Abdalla TH; Mhmoud NA; Siddig EE; Fahal AH
Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):431-435. PubMed ID: 33682008
[TBL] [Abstract][Full Text] [Related]
28. A possible role for ticks in the transmission of Madurella mycetomatis in a mycetoma-endemic village in Sudan.
Azrag RS; Bakhiet SM; Mhmoud NA; Almalik AM; Mohamed AH; Fahal AH
Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):364-374. PubMed ID: 33690861
[TBL] [Abstract][Full Text] [Related]
29. Phylogeny and typification of Madurella mycetomatis, with a comparison of other agents of eumycetoma.
de Hoog GS; Adelmann D; Ahmed AO; van Belkum A
Mycoses; 2004 Apr; 47(3-4):121-30. PubMed ID: 15078428
[TBL] [Abstract][Full Text] [Related]
30. Application of Isothermal Amplification Techniques for Identification of Madurella mycetomatis, the Prevalent Agent of Human Mycetoma.
Ahmed SA; van de Sande WW; Desnos-Ollivier M; Fahal AH; Mhmoud NA; de Hoog GS
J Clin Microbiol; 2015 Oct; 53(10):3280-5. PubMed ID: 26246484
[TBL] [Abstract][Full Text] [Related]
31. An ultrastructural study of pale eumycetoma grains.
Hay RJ; Collins MJ
Sabouraudia; 1983 Dec; 21(4):261-9. PubMed ID: 6686344
[TBL] [Abstract][Full Text] [Related]
32. Abdominal wall mycetoma presented as obstructed incisional hernia of cesarean section in eastern Sudan.
Elhardello OA; Adam ES; Adam I
Infect Dis Obstet Gynecol; 2009; 2009():74643. PubMed ID: 17485822
[TBL] [Abstract][Full Text] [Related]
33. Th-1, Th-2 Cytokines Profile among Madurella mycetomatis Eumycetoma Patients.
Nasr A; Abushouk A; Hamza A; Siddig E; Fahal AH
PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004862. PubMed ID: 27434108
[TBL] [Abstract][Full Text] [Related]
34. Phylogenetic analysis of the complete mitochondrial genome of Madurella mycetomatis confirms its taxonomic position within the order Sordariales.
van de Sande WW
PLoS One; 2012; 7(6):e38654. PubMed ID: 22701687
[TBL] [Abstract][Full Text] [Related]
35. Madurella mycetomatis infection of the buttock in an Eritrean refugee in Switzerland: a case report.
Mekoguem C; Triboulet C; Gouveia A
J Med Case Rep; 2019 Feb; 13(1):32. PubMed ID: 30755254
[TBL] [Abstract][Full Text] [Related]
36. A murine model of Madurella mycetomatis eumycetoma.
Ahmed AO; van Vianen W; ten Kate MT; van de Sande WW; van Belkum A; Fahal AH; Verbrugh HA; Bakker-Woudenberg IA
FEMS Immunol Med Microbiol; 2003 Jun; 37(1):29-36. PubMed ID: 12770757
[TBL] [Abstract][Full Text] [Related]
37. The First Case of
Siddig EE; Ahmed A; Eltigani HF; Bakhiet SM; van de Sande WWJ; Fahal AH
J Fungi (Basel); 2023 Jul; 9(7):. PubMed ID: 37504719
[TBL] [Abstract][Full Text] [Related]
38. VNTR confirms the heterogeneity of Madurella mycetomatis and is a promising typing tool for this mycetoma causing agent.
Lim W; Eadie K; Horst-Kreft D; Ahmed SA; Fahal AH; van de Sande WWJ
Med Mycol; 2019 Jun; 57(4):434-440. PubMed ID: 30085253
[TBL] [Abstract][Full Text] [Related]
39. Isolation and identification of Madurella mycetomatis from two cases of black grain mycetoma in Libya.
Ellabib MS; Refaai A; Khalifa Z; Kavanagh K
Mycoses; 2003 Sep; 46(8):339-41. PubMed ID: 12950906
[TBL] [Abstract][Full Text] [Related]
40. Fructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis.
de Klerk N; de Vogel C; Fahal A; van Belkum A; van de Sande WW
Med Mycol; 2012 Feb; 50(2):143-51. PubMed ID: 21728753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
